#NORML #News Source: @norml @WeedConnection Posted By: firstname.lastname@example.org media :: news - Tue, 14 Aug 2018 04:20:21 PST
NORML PAC Endorses Senator Bernie Sanders for Reelection
Washington, DC: The National Organization for the Reform of Marijuana Laws Political Action Committee (NORML PAC) has endorsed Senator Bernie Sanders in his campaign for reelection in Vermont.
"Bernie has become one of the most outspoken and visible advocates for ending marijuana prohibition," stated NORML PAC Executive Director Erik Altieri, "He has called for sensible drug policy throughout his career, made descheduling marijuana a key component of his platform when running for the Democratic nomination for President in 2016, and has co-sponsored key pieces of federal legislation such as the Marijuana Justice Act. Senator Sanders doesn't restrict his fight for reform to backroom meetings and floor speeches in Congress, he takes our message with him as he holds massive rallies and town halls across not just the state of Vermont, but throughout the country. His fire and passion have helped elevate our issue in the national dialogue and we are honored to support his reelection campaign. He is a true leader in the marijuana legalization revolution."
Study: Use Of CBD Products For Health Becoming Widespread
San Diego, CA: The use of cannabidiol products for the treatment of either a specific health condition or for general well-being is becoming prevalent among the general public, according to survey data published in the journal Cannabis and Cannabinoid Research.
Researchers at San Diego State University and at the National University of Natural Medicine in Portland, Oregon surveyed a self-selected cohort of 2,409 respondents with regard to their use of CBD products. Respondents typically ranged between 55 and 74 years of age.
Almost 62 percent of respondents reported using CBD for the purposes of treating a specific medical condition. The top three most commonly cited medical conditions were pain, anxiety, and depression. Almost 36 percent of subjects reported that CBD treats their medical conditions "very well by itself," while only 4.3 percent reported the substance to be largely ineffective.
Authors concluded: "The use of CBD among individuals for both specific health conditions and general health and well-being is widespread. ... CBD is being used as a specific therapy for a number of diverse medical conditions - particularly pain and inflammatory disorders, in addition to anxiety, depression, and sleep disorders. A large percentage of respondents indicate that CBD treats their condition(s) effectively in the absence of conventional medicine and with non-serious adverse effects. These data provide a compelling rationale for further research to better understand the therapeutic potential of CBD in treating chronic pain, anxiety, depression, sleep disorders, and other medical conditions."
Full text of the study, "A cross-sectional study of cannabidiol users," appears in Cannabis and Cannabinoid Research.
Colorado: Retail Marijuana Sales Not Associated With Increased Youth Access Or Use
Aurora, CO: The establishment of retail cannabis sales for adults is not associated with either increased marijuana access or use by young people, according to data published online in the journal Prevention Science.
A team of investigators with the University of Colorado, School of Public Health assessed marijuana use trends among a representative sample of Colorado high-school students for the years just prior to the implementation of retail sales and again 18-months later.
Authors reported: "There was an absence of significant effects for change in lifetime or past 30-day marijuana use. Among those reporting past 30-day use, frequent use and use on school property declined. There was a significant decline in the perceived harm associated with marijuana use, but we did not find a significant effect for perceived wrongfulness, perceived ease of access, or perceived parental disapproval."
They concluded, "We did not find a significant effect associated with the introduction of legal sales of recreational marijuana to adults in Colorado on adolescent (illegal) use."
The data is consistent with prior studies finding that neither the enactment of medical cannabis legalization nor the enactment of adult use regulation is independently associated with increased marijuana use by young people. Separate survey data released by the Department of Public Health and Environment last month reported that rates of marijuana use by Colorado teens have remained virtually unchanged following legalization, and are consistent with the national average.
Full text of the study, "Adolescent marijuana use, marijuana-related perceptions, and use of other substances before and after initiation of retail marijuana sales in Colorado (2013-2015)," appears in Prevention Science.
Oklahoma: Restrictive Medical Cannabis Rules Rescinded
Oklahoma City, OK: Republican Gov. Mary Fallin signed legislation on Monday rescinding a series of restrictive amendments to the state's voter-initiated medical marijuana access law. Many of the amendments, which were previously signed into law by the Governor just weeks prior, had been characterized as unconstitutional by the state's Attorney General.
The newly codified rules lift the Health Department's previously imposed ban on the retail sale of herbal cannabis, eliminates the requirement that dispensaries hire state-licensed pharmacists, and no longer mandate that women of childbearing age undergo a pregnancy test prior to receiving a medical cannabis recommendation. No such restrictions initially appeared in State Question 788.
The new rules also remove amendments that sought to set arbitrary limits on the THC content of medical cannabis products, and that would have prohibited dispensaries from selling cannabis plants and seedlings to qualified patients, among other changes.
Further changes to the program may be considered by the legislature. Fifty-seven percent of voters approved State Question 788 on June 28.
Study: Nighttime Use Of Herbal Cannabis Associated With Subjective Improvements In Insomnia Symptoms
Albuquerque, NM: The use of herbal cannabis is associated with reductions in self-perceived insomnia severity, according to data published in the online, open-access journal Medicines.
University of New Mexico researchers assessed the influence of marijuana use on perceived insomnia severity levels in 409 subjects. Study participants recorded real-time ratings of their symptom severity on a zero to 10-point scale using a mobile software application.
Authors reported that subjects "experienced a statistically and clinically significant improvement (−4.5 points on a zero to 10-point scale) in perceived insomnia levels. However, products made with C. sativa were associated with less symptom relief and more negative side effects than products made from C. indica or hybrid plant subtypes." They added, "CBD potency levels were associated with greater symptom relief than were THC levels."
Researchers concluded: "[O]ur results show that consumption of Cannabis flower is associated with significant improvements in perceived insomnia with differential effectiveness and side effect profiles. The widespread apparent use of cannabis as a sleep aid underscores the importance of further medical research regarding its risk-benefit profile and the effectiveness of cannabis as a substitute for other substances, including alcohol, over-the-counter and prescription sleep aids, and scheduled medications (e.g., opioids and sedatives), many of which are used in part as sleep aids."
Full text of the study, "Effectiveness of natural medical cannabis flower for treating insomnia under naturalistic conditions," appears in Medicines.